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ackground: The epidemiological study of Hepatitis caused by Hepatitis C viruses during 
pregnancy is absolutely necessary for program managers and health planners. Currently, enough 
data exist regarding viral hepatitis among pregnant women in various districts of KP, Pakistan, 
however, proper published data from district Nowshera is not available. The study was aimed at 
determining the prevalence of hepatitis C infection along with its associated risk factors among pregnant 
women who attended the antenatal clinics at district Nowshera, KP. 
Methods: One hundred and fifty (150) blood samples were obtained from pregnant women attending 
antenatal centers at district headquarter hospital Nowshera. Rapid immune-chromatographic technique 
(ICT) was used for detection of antibodies against HCV. Further confirmation of antibodies was done 
using Enzyme Linked Immunosorbent Assay (ELISA) followed by Reverse-transcription polymerase 
chain reaction (RT-PCR) for detection of HCV-RNA. 
Results: Among 150 pregnant women, 7(4.66%) were positive for HCV of which 5(3.33%) were found 
positive for Anti-HCV antibodies while 2(1.33%) showed positivity for HCV-RNA. A significant 
association of age (ݔ2 = 9.345, df = 3, P = 0.025), Gravidity (ݔ2 = 9.15, df = 2, P = 0.010), education (ݔ2 = 
48.00, df = 5, P = 0.000), and Blood Transfusion (ݔ2 = 4.629, df = 1, P = 0.031) was found with prevalence 
of HCV. 
Conclusion: The study revealed 4.66% HCV prevalence among pregnant women of district Nowshera.  
The age, gravidity, and blood transfusion were the risk factors found significantly associated with HCV 
positivity in pregnant women. Additionally, the educational level of these women was also linked with the 
viral infection. 
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Introduction  
Hepatitis C viral infection is a worldwide health 
problem. According to an estimate by World Health 
Organization (WHO), 3% of the world's populations 
have chronic HCV infections, of which the highest HCV 
prevalence rate is reported from Africa [1, 2]. The most 
efficient mode of HCV transmission is direct 
percutaneous inoculation. Many studies have 
demonstrated that household, occupational, sexual and 
vertical transmissions of HCV are also important as 
contributing factors [3]. It has been estimated that more 
than 170 million chronic HCV carriers across the  world 
having risks of developing hepatic(liver) cancer, liver 
cirrhosis or both [4]. It is thought of as an important 
cause of jaundice and acute hepatitis in pregnancy and 
other complications [5].  
Primarily, HCV spreads by direct contact with human 
blood [6]. However, during pregnancy, HCV was found 
to be associated with a high rate of vertical transmission, 
high risks of maternal complications, neonatal and fetal 
hepatitis. It has also been reported as major cause of 
maternal mortality [7-10].  
Screening of blood products for hepatitis C viral 
antibodies has reduced such mode of HCV acquisition 
and leave the vertical transmission as a predominant 
mode of infection in infants. It is worthy to note that 
women who have caesarean section, vaginal birth or any 
other gynecological procedure which require blood 
transfusion are always have risk of hepatitis C. Vertical 
transmission of hepatitis C virus might occur during 
lactation, at conception, perinatally or in utero but its 
actual mechanism of transmission, including timing is 
still undiscovered [11]. In developed countries, the most 
common cause of HCV infection in children is 
maternal-child transmission (MCT) with an estimated 
rate of 5% transmission [12].  
Currently, no vaccine is available to prevent hepatitis 
viral infection. Treatment for chronic hepatitis C is too 
costly for a person in developing countries.  From the 
global perspective, efforts should be made to reduce risk 
of HCV transmission from nosocomial (hospital 
acquired) exposure, blood transfusion and unsafe 
injections practices [1]. Given that childbearing women 
have high risk of transmitting HCV infection, there is 
dire need to identify HCV carriers among women in the 
district under study. This study therefore is aimed at the 
detection of pregnant women with HCV infection, 
increasing awareness about viral hepatitis and aiding 
health care providers for the management of infected 
individuals. It is also aimed at preventing emanating 
complications of HCV and to diminish its attendant 
socio-economic load in the study area assuming its 
presence is established.  
Methods 
Study area: The study was hospital based and the 
sampling was carried out at district headquarter hospital 
Nowshera. Due ethical clearance was taken for the study.  
Study population:  One hundred and fifty (150) blood 
samples were obtained from women attending antenatal 
clinics at district headquarter hospital Nowshera. 
Informed consent was taken from every participant.  A 
structured questionnaire was designed to obtain their 
socio-demographic predispositions and risk factors 
(Table1) that exposed individuals to HCV infection. 
Collection of blood sample and processing: 10ml of 
blood was obtained from the arm by venepuncture after 
disinfection with 70% alcohol. Five ml of the sample was 
placed in sterile labelled test tubes and allowed to clot. 
The sera were separated out into pre-labelled vials and 
were stored at -20oC until tested for detection of 
antibodies while rest of 5ml of samples were used for the 
detection of HCV-RNA. 
Screening for HCV antibodies: Rapid immuno-
chromatographic technique (ICT) was used for the 
detection of HCV-antibodies. Further confirmation of 
antibodies was done using ELISA. Manufacturer’s 
instructions were strictly adhered to IVD-REF E0320 
micro-plate ELISA.  
Screening for HCV-RNA:  Reverse-transcription 
polymerase chain reaction (RT-PCR) was used to test 
the blood samples for the presence of HCV-RNA using 
Sacace Kit HCV Real-TM Qual. 
Statistical analysis: The data obtained were entered in 
computer and checked twice before analysis using SPSS 
20.0 version. The means and percentages were 
calculated. To compare the means and percentages 
between the sero-positive and sero-negative (HCV), 
Chi-square test was used. The age, gravidity, education 
and some other possible risk factors were taken as 
independent variable. The p-values less than 0.05 were 
considered as significant. 
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Results 
Among 150 pregnant women, 7 (4.66%) were positive 
for HCV of which 5 (3.33%) were found positive for 
Anti-HCV while 2 (1.33%) were positive for HCV-RNA. 
 
Figure 1: Frequency of HCV among pregnant women of District 
Nowshera, KP 
To test the association between different risk factors and 
prevalence of HCV, Chi-square test of association was 
utilized. Several different factors were tested for their 
association with HCV. A total of 19 different factors 
namely: age, education, gravidity, dilation and curettage 
(D&C),  history of abortion, cesarean section, blood 
transfusion,  history of general surgery, tooth surgery, 
jaundice, accidents, cuts, use of injections, tattooing, 
family history of liver disease/jaundice, traveling abroad, 
residential status and awareness were tested for 
association with prevalence of HCV. The results 
obtained were of mixed type, 15 factors namely  Dilation 
and curettage(D&C),  history of abortion, cesarean 
section,  history of general surgery, tooth surgery, 
jaundice, accidents, cuts, use of injections, tattooing,  
family history of liver disease/jaundice, traveling abroad, 
residential status and awareness were found to have no 
significant relationship with prevalence of HCV. 
However, the results reveal a significant association of 
age (ݔ2 = 9.345, DF = 3, P = 0.025), Gravidity (ݔ2 = 9.15, 
DF = 2, P = 0.010), education (ݔ2 = 48.00, DF = 5, P = 
0.000), and blood transfusion (ݔ2 = 4.629, DF = 1, P = 
0.031) with prevalence of HCV (Table1). 
HCV positivity was confined to women of age group 
26-35 years. Statistically, there exist a significant 
difference in association between seroprevalence of 
HCV and age (p=0.025). 
The seroprevalence of HCV with respect to 
demographics indicated that except for age, gravidity, 
education and blood transfusion rest of the factors did 
not play a main role in disease contraction. 
Factor Chi-Value Df* P-value 
Age 9.345 3 0.025 
Education 48.002 5 0.000 
Gravidity  9.155 2 0.010 
D&C 0.826 1 0.363 
H/o Abortion  1.045 1 0.307 
Cesarean section 2.231 3 0.526 
Blood transfusion 4.629 1 0.031 
H/o General surgery 0.402 1 0.526 
H/o Dental surgery 0.015 1 0.904 
Family H/o jaundice 2.418 1 0.120 
Awareness  0.723 1 0.395 
History of jaundice 1.61 1 0.204 
H/o hospitalization 0.015 1 0.904 
H/o cuts 0.347 1 0.556 
H/o accidents 2.071 1 0.150 
Use of Injections 1.861 1 0.172 
Tattooing  0.201 1 0.654 
Travel abroad 1.037 1 0.309 
Residential status 0.414 3 0.937 
Table 1:  Chi square analysis of possible risk factors for HCV in 
pregnant women of district Nowshera 
Factor HCV Total* 
Age Negative Positive  
16-25 75(52.4%) 0(0.00%) 75(50%) 
26-35 59(41.3%) 7(100%) 66(44%) 
36-45 8(5.6%) 0(0%) 8(5.3%) 
46-55 1(0.7%) 0(0%) 1(0.7%) 
Education 
Middle  1(0.7%) 0(0%) 1(0.7%) 
Secondary 12(8.4%) 1(14.3%) 13(8.7%) 
Higher secondary 10(7.0%) 1(14.3%) 11(7.3%) 
Bachelors 3(2.1%) 4(57.1%) 7(4.7%) 
Masters 3(2.1%) 0(0%) 3(2.0%) 
Gravidity 
Primigravid 62(50.0%) 0(0.00%) 62(47.3%) 
Multigravida 48(38.7%) 4(57.1%) 52(39.7%) 
Grand multigravida  14(11.3%) 3(42.9%) 17(13.0%) 
Ear and nose piercing 
Yes 90(63.4%) 6(85.7%) 96(64.4%) 
No 52(36.6%) 1(14.3%) 53(35.5%) 
Awareness 
Yes 40(28.0%) 3(42.9%) 43(28.7%) 
No 103(72.0%) 4(37.1%) 107(71.3%) 
Tattooing 
Yes  4(2.8%) 0(0.00%) 4(2.7%) 
No  139(97.2%) 7(100%) 146(97.3%) 
Travel abroad 
Yes  7(5.2%) 1(14.3%) 8(5.6%) 
No  128(94.8%) 6(85.7%) 134(94.4%) 
Occupation 
House wife 128(89.5%) 7(100%) 135(90.0%) 
Working lady 11(7.7%) 0(0.00%) 11(7.3%) 
Residential Status 
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Rural 96(67.1%) 5(71.4%) 101(67.3%) 
Urban 43(30.1%) 2(28.6%) 45(30.0%) 
Table 2: HCV prevalence correlated with socio-demographics 
Factor HCV Total* 
Negative Positive 
Dilation and curettage  
Yes 57(39.9%) 4(57.1%) 61(40.7%) 
No 86(60.1%) 3(42.9%) 89(59.3%) 
 History of Abortion  
Yes 43(30.3%) 3(50.0%) 46(31.1%) 
No 99(69.7%) 3(50.0%) 102(68.9%) 
History of liver jaundice 
Yes 27(18.9%) 0(0.00%) 27(18.0%) 
No 116(81.1%) 7(100%) 123(82%) 
History of blood transfusion 
Yes 31(21.8%) 4(57.1%) 35(23.4%) 
No 111(78.2%) 3(42.9%) 114(76.5%) 
History of general surgery 
Yes  27(18.9%) 2(28.6%) 29(19.3%) 
No 116(81.1%) 5(71.4%) 121(80.7%) 
History of dental surgery 
Yes  58(40.6%) 3(42.9%) 61(40.7%) 
No 85(59.4%) 4(57.1%) 89(59.3%) 
Family history of liver disease 
Yes 63(44.1%) 1(14.3%) 64(42.7%) 
No 80(55.9%) 6(85.7%) 86(57.3%) 
History of hospitalization 
Yes  58(40.6%) 3(42.9%) 61(40.7%) 
No  85(59.4%) 4(57.1%) 89(59.3%) 
History of cuts 
Yes  46(32.2%) 3(42.9%) 49(32.7%) 
No  97(67.8%) 4(57.1%) 101(67.3%) 
History of accidents 
Yes  33(23.1%) 0(0.00%) 33(22.0%) 
No  110(76.9%) 7(100%) 117(78.0%) 
Use of therapeutic injections 
Yes  30(21.0%) 3(42.9%) 33(22.0%) 
No  113(79.0%) 4(57.1%) 117(78.0%) 
Table 3: HCV associated with risk factors 
Discussion  
This study is the first document being published on 
prevalence of HCV among pregnant women of district 
Nowshera, KP. Different epidemiologic studies have 
shown HCV seroprevalence in Pakistan with a range of 
0.7% to 20% [13]. In our study, 4.66% of the pregnant 
women were found positive for HCV which is 
comparable with the findings of other such 
epidemiologic study [14]. 
Our finding of 4.66% prevalence has vital health 
implications for the large number of pregnant women 
and their families who dwell in our location of study. 
This is because the majority of the infected women were 
ignorant of HCV infection and were not aware of their 
infection status as they were asymptomatic. This imply 
that there is substantial potential for transmission of 
HCV infection to other people in their surrounding 
especially to fetuses. Our finding is parallel to a report 
from Mardan, which showed 4.34% prevalence of HCV 
[15] and that of 5.31% in a study at Islamabad [16]. 
The seroprevalence of HCV in our study was low 
when compared with that described previously in a 
study conducted in 2002 in Sindh, Pakistan which 
showed high HCV prevalence rate of 9% [17].  These 
pragmatic differences may be attributed to the degree of 
exposure to risk factors in our study populations as we 
found out that demographic variables considered in 
study had no statistical significance with HCV 
seropositivity.  
Studies by Khan in 2004 and Muhammad 2004 has 
showed history of reused syringes, dental procedure, 
surgical operation, blood transfusion and tattooing as 
significant risk [18,19]. Similarly, study by Batash also 
showed that intramuscular injections and blood 
transfusions were significantly associated with HCV 
seropositivity [20]. Our results again reiterate their 
findings as blood transfusion (ݔ2 = 4.629, DF = 1, P = 
.031) and Gravidity (ݔ2 = 9.15, DF = 2, P = .010) to be 
significantly associated with HCV.  
Similarly, studies by Cacoub found transfusion of 
blood products (P < 0.0001), and dental treatment (P < 
0.0001) and Nafeh showed previous blood transfusions 
and sexual contacts with intravenous drug user [21, 22] 
as factors associated with HCV. Delage also showed 
intravenous drug use (P value 0.001) and blood 
transfusion (P value 0.01) to be statistically significant 
factors similar to our study [23].  
As far the age groups screened, the highest prevalence 
of 100% was recorded among pregnant women of age 
group 26-35 years. This result agrees with the result in 
other studies which showed increase in HCV 
seroprevalence with increase in age [24]. Interestingly, 
statistical analysis showed a significant association 
between the age and HCV positivity (P = 0.025). 
This was also interesting to note that in our study 
many factors like dilation and curettage (D&C),  history 
of abortion, cesarean section,  history of general surgery, 
tooth surgery, jaundice, accidents, cuts, use of injections, 
tattooing, family history of liver disease/jaundice, 
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traveling abroad, residential status and awareness were 
found to have no significant relationship with 
prevalence of HCV. The possible justification was 
female sample population selected. As tattooing and 
traveling to abroad is not common in females of our 
society.  
The study revealed a high rate of 4.66% HCV 
prevalence among pregnant women of district 
Nowshera.  The age, gravidity, and blood transfusion 
were the risk factors found significantly associated with 
HCV positivity in pregnant women. Additionally, the 
educational level of these women was also linked with 
the infection. 
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